TY - JOUR
T1 - Imparting Immunomodulatory Activity to Scaffolds via Biotin-Avidin Interactions
AU - Lurier, Emily B.
AU - Nash, Victoria A.
AU - Abee, Hannah S.
AU - Wissing, Tamar B.
AU - Bouten, Carlijn V.C.
AU - Smits, Anthal I.P.M.
AU - Spiller, Kara L.
PY - 2021/12/13
Y1 - 2021/12/13
N2 - Biotin-avidin interactions have been explored for decades as a technique to functionalize biomaterials, as well as for in vivo targeting, but whether changes in these interactions can be leveraged for immunomodulation remain unknown. The goal of this study was to investigate how biotin density and avidin variant can be used to deliver the immunomodulatory cytokine, interleukin 4 (IL4), from a porous gelatin scaffold, Gelfoam, to primary human macrophages in vitro. Here, we demonstrate that the degree of scaffold biotinylation controlled the binding of two different avidin variants, streptavidin and CaptAvidin. Biotinylated scaffolds were also loaded with streptavidin and biotinylated IL4 under flow, suggesting a potential use for targeting this biomaterial in vivo. While biotin-avidin interactions did not appear to influence the protein release in this system, increasing degrees of biotinylation did lead to increased M2-like polarization of primary human macrophages over time in vitro, highlighting the capability to leverage biotin-avidin interactions to modulate the macrophage phenotype. These results demonstrate a versatile and modular strategy to impart immunomodulatory activity to biomaterials.
AB - Biotin-avidin interactions have been explored for decades as a technique to functionalize biomaterials, as well as for in vivo targeting, but whether changes in these interactions can be leveraged for immunomodulation remain unknown. The goal of this study was to investigate how biotin density and avidin variant can be used to deliver the immunomodulatory cytokine, interleukin 4 (IL4), from a porous gelatin scaffold, Gelfoam, to primary human macrophages in vitro. Here, we demonstrate that the degree of scaffold biotinylation controlled the binding of two different avidin variants, streptavidin and CaptAvidin. Biotinylated scaffolds were also loaded with streptavidin and biotinylated IL4 under flow, suggesting a potential use for targeting this biomaterial in vivo. While biotin-avidin interactions did not appear to influence the protein release in this system, increasing degrees of biotinylation did lead to increased M2-like polarization of primary human macrophages over time in vitro, highlighting the capability to leverage biotin-avidin interactions to modulate the macrophage phenotype. These results demonstrate a versatile and modular strategy to impart immunomodulatory activity to biomaterials.
KW - biotin-avidin
KW - drug delivery
KW - immunomodulation
KW - interleukin 4
KW - macrophage polarization
UR - http://www.scopus.com/inward/record.url?scp=85119411621&partnerID=8YFLogxK
U2 - 10.1021/acsbiomaterials.1c01190
DO - 10.1021/acsbiomaterials.1c01190
M3 - Article
C2 - 34767332
SN - 2373-9878
VL - 7
SP - 5611
EP - 5621
JO - ACS Biomaterials Science and Engineering
JF - ACS Biomaterials Science and Engineering
IS - 12
ER -